Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
07/09/2013 | US8481537 Caspase inhibitors based of pyridazinone scaffold |
07/09/2013 | US8481527 Benzamide derivatives as bradykinin antagonists |
07/09/2013 | US8481513 3, 10, and 12a substituted tetracycline compounds |
07/09/2013 | US8481091 Pharmaceutical compositions |
07/09/2013 | US8481053 Compositions and methods for treating of microbial infections |
07/09/2013 | CA2640994C Enamel matrix protein composition for preventing or treating infection |
07/09/2013 | CA2588221C Modified chimeric polypeptides with improved pharmacokinetic properties |
07/09/2013 | CA2577408C Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators |
07/09/2013 | CA2567694C Novel galactoside inhibitors of galectins |
07/09/2013 | CA2566931C Tablets exhibiting reduced drug release variability |
07/09/2013 | CA2558600C A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4 |
07/09/2013 | CA2408408C Modulators of tnf- alpha signaling |
07/04/2013 | WO2013102123A2 Aglycosylated human antibody and fusion protein and uses thereof |
07/04/2013 | WO2013101949A2 Composition and method for compounded therapy |
07/04/2013 | WO2013101926A1 Benzimidazole derivatives as selective blockers of persistent sodium current |
07/04/2013 | WO2013101911A2 Benzimidazole derivatives as selective blockers of persistent sodium current |
07/04/2013 | WO2013101810A1 Formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetyl aminoisoindoline-1,3-dione |
07/04/2013 | WO2013100774A1 Pharmaceutical compositions containing herbal based active ingredients for application in human and veterinary medicine |
07/04/2013 | WO2013098049A1 Prevention or treatment of painful polyneuropathies by administration of an aluminosilicate |
07/04/2013 | WO2013051024A3 Quinoline-, quinoxaline or benzothiazole based cysteinyl leukotriene antagonists (ltc4) |
07/04/2013 | WO2013048145A3 Composition for preventing or treating inflammatory diseases or diseases related to bone mass reduction, containing 6-(3-hydroxyphenyl)-2-naphthol or pharmaceutically acceptable salt thereof as active ingredient |
07/04/2013 | WO2013036904A3 Methods, agents and peptides for inhibiting matrix metalloproteinase-2 signaling |
07/04/2013 | WO2013010136A3 Inhibitors of bruton's tyrosine kinase |
07/04/2013 | US20130172352 5-membered heterocycle-based p38 kinase inhibitors |
07/04/2013 | US20130172349 Inhibitors of phosphatidylinositol 3-kinase |
07/04/2013 | US20130172314 PYRAZOLO[3,4-d]PYRIMIDINE AND PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS KINASE INHIBITORS |
07/04/2013 | US20130171275 Use of bamboo vinegar for treating inflammation |
07/04/2013 | CA2861202A1 Novel nicotinamide derivative or salt thereof |
07/04/2013 | CA2857347A1 Composition and method for compounded therapy |
07/03/2013 | EP2610619A1 Hemokinin-1 receptor and hemokinin-1-derived peptide |
07/03/2013 | EP2610244A1 Indole compounds |
07/03/2013 | EP2610242A1 Positively charged water-soluble prodrugs of aspirin |
07/03/2013 | EP2609934A1 Receptor And Antigen Targeted Prodrug |
07/03/2013 | EP2609926A1 Prevention or Treatment of Painful Polyneuropathies by Administration of an Aluminosilicate |
07/03/2013 | EP2609108A1 Certain chemical entities, compositions, and methods |
07/03/2013 | EP2609098A1 Triazolopyrazine derivatives |
07/03/2013 | EP2609095A2 Compounds that modulate intracellular calcium |
07/03/2013 | EP2609092A1 Oxadiazole inhibitors of leukotriene production |
07/03/2013 | EP2609078A1 Hydroxamate-based inhibitors of deacetylases |
07/03/2013 | EP2608801A2 INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES |
07/03/2013 | CN103189374A Prophylactic or therapeutic agent for non-alcoholic steatohepatitis |
07/03/2013 | CN103189353A Hydroxamate-based inhibitors of deacetylases |
07/03/2013 | CN103183738A Compositions and methods of use for antibodies of c-MET |
07/03/2013 | CN103183726A Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
07/03/2013 | CN103183675A Phosphodiesterase-4 inhibitor |
07/03/2013 | CN103183660A Chromane derivative used as TRPV3 (transient receptor potential vanilloid 3) conditioning agent |
07/03/2013 | CN103183659A Chromane derivative used as TRPV3 (transient receptor potential vanillin 3) regulator |
07/03/2013 | CN103183646A Preparation method for 3-(2-isobutoxy-5-(6-isobutoxy-1,2-benzoisoxzzole)phenyl)propionic acid compound and application of the compound in medicine |
07/03/2013 | CN103183634A 3-(2-isobutyl-5-(4-isobutylpiperidine-1-carbonyl)phenyl)propionic acid and preparation method thereof |
07/03/2013 | CN103183630A Substituted 4-aminocyclohexane derivatives |
07/03/2013 | CN103182062A Arthritis-relieving dropping pill for treating osteoarthrosis and preparation method thereof |
07/03/2013 | CN103182060A Heumatism plaster |
07/03/2013 | CN103182052A Traditional Chinese medicine for treating sciatica |
07/03/2013 | CN103182010A Qi-promoting blood-activating collaterals-dredging pain-relieving capsules |
07/03/2013 | CN103181997A Method for processing bittersweet herb |
07/03/2013 | CN103181972A Tablet or capsule of traditional Chinese medicine for treating wind-heat type common cold and upper respiratory infection, and preparation method thereof |
07/03/2013 | CN103181961A Preparation method of flavonoid medicine for treating frostbite |
07/03/2013 | CN103181957A Preparation technology capable of completely removing acute toxicity of prepared aconite roots and keeping pharmacological activity of prepared aconite roots |
07/03/2013 | CN103181956A Percutaneous absorption plaster for treating degenerative osteoarthropathy |
07/03/2013 | CN103181952A Roxburgh engelhardtia extractive for preventing and treating autoimmune diseases and preparation method thereof |
07/03/2013 | CN103181942A Medicine preparation with cruciferous plant extract as active component |
07/03/2013 | CN103181935A Method for extracting medical total flavone from cupressus chengiana |
07/03/2013 | CN103181922A Application of piperidone-containing single-carbonyl curcumin compound in preparation of anti-inflammatory drug |
07/03/2013 | CN103181911A Vaginal effervescent tablets |
07/03/2013 | CN103181894A Nabumetone spraying agent and preparation method |
07/03/2013 | CN103181891A Andrographolide injection and preparation method thereof |
07/03/2013 | CN103181877A Whitening capsules |
07/03/2013 | CN103181564A Nutritional composition for immune condition |
07/03/2013 | CN102441113B Bergenia scopulosa traditional Chinese medicinal composition and preparation method thereof |
07/03/2013 | CN102441089B Traditional Chinese herbal composition for lumbar vertebra rheumatic pain and preparation method thereof |
07/03/2013 | CN102406940B Application of nanoscale flaky carboxymethyl starch sodium in solid dispersion |
07/03/2013 | CN102388812B Beef cattle nose ring |
07/03/2013 | CN102366473B Oral traditional Chinese medicine preparation for treating swine high fever disease and preparation method thereof |
07/03/2013 | CN102335317B Cold-prevention and body-building snake medical wine |
07/03/2013 | CN102335290B Antirheumatic and hyperglycemic snake medical wine |
07/03/2013 | CN102327532B Capsule for treating rheumatism and rheumatoid arthritis |
07/03/2013 | CN102241737B Endomorphin-1 analogs, synthesis thereof and application of endomorphin-1 analogs in preparation of analgesic medicines |
07/03/2013 | CN102219811B CA-4 derivatives and preparation method and medicinal application thereof |
07/03/2013 | CN102028912B Externally applied traditional Chinese medicine powder for diminishing inflammation and swelling |
07/03/2013 | CN102018696B Skin external preparation containing lidocaine or pharmaceutical salt thereof |
07/03/2013 | CN101945877B Pyrrolopyrazine kinase inhibitors |
07/03/2013 | CN101711835B Formula of traditional Chinese medicines for treating soft tissue injury and method for preparing preparation thereof |
07/03/2013 | CN101679413B New 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives |
07/03/2013 | CN101659689B Methylprednisolone derivative |
07/03/2013 | CN101480419B Polysaccharide extract of Periploca forrestii Schltr, and preparation method thereof |
07/03/2013 | CN101309601B High-potency sweetener composition with an anti-inflammatory agent and compositions sweetened therewith |
07/02/2013 | US8476456 Process for the preparation of 4-(imidazol-1-yl)benzenesulfonamide derivatives |
07/02/2013 | US8476282 Benzoxazole kinase inhibitors and methods of use |
07/02/2013 | US8476220 Biocompatible polymers, process for their preparation and compositions containing them |
07/02/2013 | US8475834 Method of improving absorption of vitamin E by a pet animal |
07/02/2013 | US8475766 Dual specificity antibodies and methods of making and using |
07/02/2013 | CA2748249C Cyclic amine compounds |
07/02/2013 | CA2599879C Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
07/02/2013 | CA2540536C Salts and polymorphs of a potent antidiabetic compound |
07/02/2013 | CA2504582C Drug delivery device comprising a bilayered polymeric coating having an inhibitor of the mamalian target of rapamycin incorporated into the first polymeric coating layer |
07/02/2013 | CA2445729C Use of metals to treat mucosal membranes |
06/27/2013 | WO2013096847A1 Serum amyloid p-antibody fusion proteins |
06/27/2013 | WO2013096496A2 Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response |
06/27/2013 | WO2013096226A1 Trpv1 antagonists |
06/27/2013 | WO2013096182A2 Compositions comprising gallates and gallamides |